LSD (Lysergic acid diethylamide)

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• US DEA: LSD (Lysergic Acid Diethylamide) — Schedule I Classification, Microgram-Level Potency, NBOMe Compound Adulteration, HPPD, and Psychedelic-Assisted Therapy Clinical Trial Overview (2022) REGULATORY · 2022
• Nichols DE: Psychedelics — Pharmacological Review; 5-HT2A Mechanism, LSD Dose-Response, Physiological Safety, HPPD Prevalence, Adolescent Psychosis Risk, and Therapeutic Applications (Pharmacological Reviews, 2016; updated 2023) ACADEMIC · 2023
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• EPA CompTox CTX API: predicted properties for DTXSID1023231 (LSD (Lysergic acid diethylamide)) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.